Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05710848
What this trial is testing

STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
SURGE Therapeutics 75
Not applicableWithdrawnNCT05714826
What this trial is testing

Comprehensive Optimization At-time of Radical Cystectomy Intervention

Who this might be right for
Bladder CancerRadical Cystectomy
University of Texas Southwestern Medical Center
Not applicableLooking for participantsNCT06026189
What this trial is testing

Safely Reduce Cystoscopic Evaluations for Hematuria Patients

Who this might be right for
HematuriaUrothelial NeoplasmUrothelial Carcinoma+1 more
Erasmus Medical Center 1,100
Not applicableLooking for participantsNCT00026884
What this trial is testing

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

Who this might be right for
Malignant NeoplasmsHereditary Neoplastic SyndromesKidney Cancer+2 more
National Cancer Institute (NCI) 5,950
Testing effectiveness (Phase 2)Active Not RecruitingNCT02989584
What this trial is testing

A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer

Who this might be right for
Bladder CancerMetastatic Bladder CancerUrothelial Carcinoma
Memorial Sloan Kettering Cancer Center 54
Not applicableStudy completedNCT05109884
What this trial is testing

Comparison of PET Imaging Patterns With PSMA and AR Expression in Prostate Cancer and Bladder Cancer

Who this might be right for
Prostate Cancer
Medical University of Vienna 10
Testing effectiveness (Phase 2)Study completedNCT02335424
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-052)

Who this might be right for
Urothelial Cancer
Merck Sharp & Dohme LLC 374
Testing effectiveness (Phase 2)Active Not RecruitingNCT05779943
What this trial is testing

Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate Carcinoma
Emory University 20
Not applicableEnded earlyNCT04142359
What this trial is testing

PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)

Who this might be right for
Pharmacokinetics
Altor BioScience 1
Not applicableStudy completedNCT03715660
What this trial is testing

Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study

Who this might be right for
Bladder Cancer
Mansoura University 198
Testing effectiveness (Phase 2)Study completedNCT03617913
What this trial is testing

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Carcinoma Infiltrating the Muscle of the Bladder WallStage II Bladder Cancer AJCC v8Stage II Renal Pelvis Cancer AJCC v8+9 more
Mayo Clinic 2
Large-scale testing (Phase 3)Looking for participantsNCT07106762
What this trial is testing

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Who this might be right for
Urothelial Cancer
Bristol-Myers Squibb 470
Early research (Phase 1)Study completedNCT01352962
What this trial is testing

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Who this might be right for
Urethral NeoplasmsNeoplasms, UrethralCancer of the Urethra+1 more
National Cancer Institute (NCI) 18
Not applicableEnded earlyNCT04412070
What this trial is testing

Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients

Who this might be right for
Bladder Cancer
Hopital Foch 20
Large-scale testing (Phase 3)Study completedNCT01812369
What this trial is testing

Perioperative Chemotherapy for Patients With Locally Advanced Bladder Cancer

Who this might be right for
Bladder Cancer
University Hospital, Rouen 500
Testing effectiveness (Phase 2)Study completedNCT00005086
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer

Who this might be right for
Bladder Cancer
University of Chicago 6
Not applicableLooking for participantsNCT05204186
What this trial is testing

Impact of COMORBIDities After Radical Cystectomy Using a Predictive Method With Artificial Intelligence

Who this might be right for
Bladder CancerComorbidityDeep Learning
Centre Hospitalier Universitaire, Amiens 500
Large-scale testing (Phase 3)Ended earlyNCT01475266
What this trial is testing

Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder Cancer
Nippon Kayaku Co., Ltd. 51
Testing effectiveness (Phase 2)Study completedNCT04919512
What this trial is testing

TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

Who this might be right for
Urinary Bladder Neoplasms
Janssen Research & Development, LLC 163
Not applicableLooking for participantsNCT06373419
What this trial is testing

TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors

Who this might be right for
Urolithiasis of Bladder
Thunder Bay Regional Health Research Institute 100
Next Page